David Germonpré

InOpSys NV develops treatments for hazardous wastewater. It designs and delivers flexible, modular and mobile units. The company was founded by Raf Dewil and Lies Appels and is headquartered in Mechelen, Belgium.

FOx Biosystems NV engages in the provision of life science research tool. It offers White Fox 1.0, a surface plasmon resonance biosensor technology. Its services include evaluation and system support and development of custom applications and devices. The company was founded by Filip Delport and Jeroen Lammertyn in 2016 and is headquartered in Temse, Belgium.

MTIP AG (MTIP) is an independent private equity/venture capital firm founded in 2014. The firm is headquartered in Basel, Switzerland.

Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland.

Gemma Frisius Fonds K.U. Leuven (GFF) is an Independent Venture Capital firm founded in 1997 as a joint venture between Katholieke Universiteit Leuven, KBC Group and BNP Paribas Group. Gemma Frisius K.U. Leuven is headquartered in Leuven.

MAGICS Instruments NV develops and sells radiation-tolerant electronic circuits for the nuclear industry. It provides MGy-level radiation services on its products or other commercial-of-the-shelf components. The company was founded by Cao Ying and Jens Verbeek on October 28, 2015 and is headquartered in Mol, Belgium.